# FDA Inspection 1266088 - R.S.A. Corp. - February 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/rsa-corp/ef2cc89d-9a04-440d-bfd1-b9da93460bc4
Source feed: FDA_Inspections

> FDA Inspection 1266088 for R.S.A. Corp. on February 21, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266088
- Company Name: R.S.A. Corp.
- Inspection Date: 2025-02-21
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1266088 - 2025-02-21](https://www.keypedia.com/records/fda_inspections/rsa-corp/a938433a-9f46-4019-8c6f-f1a527b72199)
- [FDA Inspection 1131411 - 2020-09-16](https://www.keypedia.com/records/fda_inspections/rsa-corp/ab8953b3-dbca-44ce-b256-9d4a63c67f6f)
- [FDA Inspection 810491 - 2012-12-12](https://www.keypedia.com/records/fda_inspections/rsa-corp/2f1932ff-3e4b-45d5-94de-508801db4679)
- [FDA Inspection 695022 - 2010-10-25](https://www.keypedia.com/records/fda_inspections/rsa-corp/e0d93b70-c0cf-484b-a008-4a44fcc07dc6)

Company: https://www.keypedia.com/companies/rsa-corp/d731050b-36e3-475d-9748-8defc5556e50

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c